Lido Advisors, LLC Lucid Diagnostics Inc. Transaction History
Lido Advisors, LLC
- $20.3 Billion
- Q3 2024
A detailed history of Lido Advisors, LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Lido Advisors, LLC holds 100,016 shares of LUCD stock, worth $100,016. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,016
Previous 68,016
47.05%
Holding current value
$100,016
Previous $55,000
49.09%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LUCD
# of Institutions
31Shares Held
2.54MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX1.15MShares$1.15 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$560,9150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA214KShares$213,5400.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT126KShares$126,3620.01% of portfolio
-
Ayrton Capital LLC Westport, CT73.9KShares$73,9073.26% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $38.6M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...